Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc scores highest on Anchor (51) and lowest on Earnings (10). Its PosiPenta is 31.33 out of 100, weaker than most similar companies.
On the Penta Grid this week, Curanex Pharmaceuticals Inc is Grid #737 of 837 in the Healthcare sector in United States, and Grid #3,536 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc | 31.33 | 33 | 10 | 30 | 33 | 51 |
| Bolt Biotherapeutics, Inc. | 32.77 | 44 | 11 | 52 | 19 | 38 |
| Vistagen Therapeutics, Inc. | 32.84 | 47 | 32 | 4 | 41 | 40 |
| Aethlon Medical, Inc. | 33.25 | 31 | 41 | 29 | 37 | 28 |
| American Shared Hospital Services | 55.17 | 47 | 81 | 42 | 46 | 60 |
| Soligenix, Inc. | 34.96 | 25 | 60 | 24 | 36 | 29 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.59 |
| P/B ratio | 1.51 |
EEarnings
| Trailing EPS | ₹-738.78 |
| Forward EPS | — |
NNitro
| Price | 437.58 |
| 52-week high | 1604.47 |
| 52-week low | 339.08 |
| Fall from 52-week high | 72.7% |
TTorque
| Return on equity (ROE) | -411.08% |
| Debt-to-equity | 0.06 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹68 Cr |
| Insider holding | 61.35% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Curanex Pharmaceuticals Inc's PosiPenta score?
Curanex Pharmaceuticals Inc's PosiPenta is 31.33 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Curanex Pharmaceuticals Inc stand on the Penta Grid?
On the Penta Grid this week, Curanex Pharmaceuticals Inc is Grid #737 of 837 in the Healthcare sector in United States, and Grid #3,536 of 4,000 in United States.
Which PosiPenta pillar is strongest for Curanex Pharmaceuticals Inc?
Anchor (stability and dividends), with a score of 51 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Curanex Pharmaceuticals Inc?
Earnings (growth), with a score of 10 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.